Literature DB >> 28040495

TIPS pentacene loaded PEO-PDLLA core-shell nanoparticles have similar cellular uptake dynamics in M1 and M2 macrophages and in corresponding in vivo microenvironments.

Dylan K McDaniel1, Ami Jo2, Veronica M Ringel-Scaia3, Sheryl Coutermarsh-Ott1, Daniel E Rothschild1, Michael D Powell3, Rui Zhang4, Timothy E Long4, Kenneth J Oestreich5, Judy S Riffle4, Richey M Davis6, Irving C Allen7.   

Abstract

Nanoparticle based drug delivery platforms have the potential to transform disease treatment paradigms and therapeutic strategies, especially in the context of pulmonary medicine. Once administered, nanoparticles disperse throughout the lung and many are phagocytosed by macrophages. However, there is a paucity of knowledge regarding cellular up-take dynamics of nanoparticles due largely to macrophage heterogeneity. To address this issue, we sought to better define nanoparticle up-take using polarized M1 and M2 macrophages and novel TIPS-pentacene loaded PEO-PDLLA nanoparticles. Our data reveal that primary macrophages polarized to either M1 or M2 phenotypes have similar levels of nanoparticle phagocytosis. Similarly, M1 and M2 polarized macrophages isolated from the lungs of mice following either acute (Th1) or allergic (Th2) airway inflammation also demonstrated equivalent levels of nanoparticle up-take. Together, these studies provide critical benchmark information pertaining to cellular up-take dynamics and biodistribution of nanoparticles in the context of clinically relevant inflammatory microenvironments.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; Inflammation; LPS; Nanoparticle; Pulmonary drug delivery

Mesh:

Substances:

Year:  2016        PMID: 28040495      PMCID: PMC5392431          DOI: 10.1016/j.nano.2016.12.015

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  36 in total

1.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

2.  The effect of particle design on cellular internalization pathways.

Authors:  Stephanie E A Gratton; Patricia A Ropp; Patrick D Pohlhaus; J Christopher Luft; Victoria J Madden; Mary E Napier; Joseph M DeSimone
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

3.  Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs.

Authors:  Chintan H Kapadia; Shaomin Tian; Jillian L Perry; J Christopher Luft; Joseph M DeSimone
Journal:  Mol Pharm       Date:  2016-09-22       Impact factor: 4.939

Review 4.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12

5.  A novel phenotype for an activated macrophage: the type 2 activated macrophage.

Authors:  Charles F Anderson; David M Mosser
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

6.  Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells.

Authors:  João Conde; Chenchen Bao; Yeqi Tan; Daxiang Cui; Elazer R Edelman; Helena S Azevedo; Hugh J Byrne; Natalie Artzi; Furong Tian
Journal:  Adv Funct Mater       Date:  2015-06-01       Impact factor: 18.808

7.  Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.

Authors:  Qingguo Xu; Laura M Ensign; Nicholas J Boylan; Arne Schön; Xiaoqun Gong; Jeh-Chang Yang; Nicholas W Lamb; Shutian Cai; Tao Yu; Ernesto Freire; Justin Hanes
Journal:  ACS Nano       Date:  2015-08-31       Impact factor: 15.881

Review 8.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

9.  Therapeutic siRNA silencing in inflammatory monocytes in mice.

Authors:  Florian Leuschner; Partha Dutta; Rostic Gorbatov; Tatiana I Novobrantseva; Jessica S Donahoe; Gabriel Courties; Kang Mi Lee; James I Kim; James F Markmann; Brett Marinelli; Peter Panizzi; Won Woo Lee; Yoshiko Iwamoto; Stuart Milstein; Hila Epstein-Barash; William Cantley; Jamie Wong; Virna Cortez-Retamozo; Andita Newton; Kevin Love; Peter Libby; Mikael J Pittet; Filip K Swirski; Victor Koteliansky; Robert Langer; Ralph Weissleder; Daniel G Anderson; Matthias Nahrendorf
Journal:  Nat Biotechnol       Date:  2011-10-09       Impact factor: 54.908

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  4 in total

1.  Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages Dramatically Enhances Selectivity and Efficacy in Vivo.

Authors:  Myungsun Shin; Helena W Snyder; Giulia Donvito; Lesley D Schurman; Todd E Fox; Aron H Lichtman; Mark Kester; Ku-Lung Hsu
Journal:  Mol Pharm       Date:  2017-09-13       Impact factor: 4.939

2.  Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR-Cas9 plasmid.

Authors:  Ami Jo; Veronica M Ringel-Scaia; Dylan K McDaniel; Cassidy A Thomas; Rui Zhang; Judy S Riffle; Irving C Allen; Richey M Davis
Journal:  J Nanobiotechnology       Date:  2020-01-20       Impact factor: 10.435

Review 3.  Pharmaceutical nanoformulation strategies to spatiotemporally manipulate oxidative stress for improving cancer therapies - exemplified by polyunsaturated fatty acids and other ROS-modulating agents.

Authors:  Rui Xue Zhang; Franky Fuh-Ching Liu; Hoyin Lip; Junhong Liu; Qianrong Zhang; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2022-01-22       Impact factor: 5.671

4.  Pulmonary Exposure to Magnéli Phase Titanium Suboxides Results in Significant Macrophage Abnormalities and Decreased Lung Function.

Authors:  Dylan K McDaniel; Veronica M Ringel-Scaia; Holly A Morrison; Sheryl Coutermarsh-Ott; McAlister Council-Troche; Jonathan W Angle; Justin B Perry; Grace Davis; Weinan Leng; Valerie Minarchick; Yi Yang; Bo Chen; Sky W Reece; David A Brown; Thomas E Cecere; Jared M Brown; Kymberly M Gowdy; Michael F Hochella; Irving C Allen
Journal:  Front Immunol       Date:  2019-11-28       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.